Medical International Research USA, Inc.

Medical International Research (MIR) is an Italy-based global leader in spirometry and pulmonary function testing with over 30 years of experience and presence in more than 100 countries. The company designs and manufactures professional-grade spirometers, portable spirometry systems, and oximetry devices for hospitals, medical centers, pulmonology clinics, and home-based respiratory monitoring. MIR offers a dual-portfolio model: professional-use diagnostic spirometers compliant with ATS/ERS guidelines for clinical and hospital settings, and personal-use smart spirometers for consumer-grade home monitoring and disease management. Products are smartphone-compatible and integrate with EHR/EMR systems via MIR Spiro Platinum software (available for Windows and macOS). The company holds multiple regulatory certifications including FDA clearance for the United States, NMPA (China), ANVISA (Brazil), COFEPRIS (Mexico), and Health Canada approval. MIR maintains several patented technologies in spirometry and oximetry. The company's products have been integrated into the UK National Health Service (NHS) governance for virtual consultation implementation. Manufacturing and distribution capabilities span three branches globally with localized support in major markets.